InvestorsHub Logo
Followers 0
Posts 142
Boards Moderated 0
Alias Born 11/30/2017

Re: None

Tuesday, 03/17/2020 11:18:16 AM

Tuesday, March 17, 2020 11:18:16 AM

Post# of 97081
The revised forecast of 525 million units does not include figures for sale to hospitals, which is also a major source of revenue.

Expect a second forecast in the near term.

Pretty huge news here. See below from this morning's press release.


"Today, in this second of four updates about our GenViro™ Swift" kit for the testing of COVID-19, we will focus on our expected roll-out. We are happy to inform all interested parties that we have raised our 12-month forecast to 525 million kits."

Mr. Berman continued, "Over the weekend, and after receiving a plan from our technical and R&D director, we decided to take the next step with GenViro™and further refine its use for hospitals. While we have not yet forecast sales to hospitals, and while most of the lesser but competitive products are directed toward hospital uses, we nonetheless believe that hospitals will be a large future source of revenues. When we complete this round of information releases, our fourth release will include a hospital forecast.


The fourth press release will include a second forecast in addition to the current 525 million unit forecast.